Population-Scale, Genotype-First Characterization of Monogenic Diabetes in 374,973 Multi-Ancestry Individuals from the All of Us Research Program
Abstract
OBJECTIVETo characterize the prevalence and penetrance of maturity-onset diabetes of the young (MODY) in a multi-ancestry population using a genotype-first design. RESEARCH DESIGN AND METHODSWe analyzed whole-genome sequencing and clinical data from 374,973 unrelated All of Us participants (42.0% non-European ancestry). We identified pathogenic or likely pathogenic (P/LP) variants in 10 established MODY genes and assessed carrier prevalence, diabetes penetrance, and glycemic profiles. We evaluated age-dependent diabetes risk by comparing carriers with non-carriers stratified by type 2 diabetes polygenic risk score (T2D PRS). RESULTSWe identified 370 carriers of P/LP MODY gene variants (0.099%; 1 in 1,013), with similar carrier prevalence among European- and African-ancestry participants (0.105% in both groups). Diabetes penetrance was incomplete (13.4% by age 40; 43.5% by age 60) and varied by etiology: highest for GCK (56.0% by age 60), intermediate for HNF genes (HNF1A/HNF1B/HNF4A; 45.4%), and lowest for non-GCK/HNF genes (ABCC8/INS/KCNJ11/NEUROD1/PDX1/RFX6; 29.0%). In multivariable Cox models using non-carriers in the middle 80% of the T2D PRS as the reference, non-GCK/HNF gene variant carriers had modestly increased diabetes risk (HR, 1.57), similar to non-carriers in the top 10% of T2D PRS (HR, 1.64). These associations were observed in both European- and non-European-ancestry individuals. HbA1c profiles differed by etiology, with stable mild hyperglycemia in GCK variant carriers and greater variability among HNF and non-GCK/HNF gene variant carriers. CONCLUSIONSMODY gene variants showed incomplete, etiology-dependent penetrance across ancestries. Carriers of P/LP variants in lower-penetrance genes had diabetes risk comparable to that of non-carriers with high polygenic susceptibility. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=129 SRC="FIGDIR/small/26355541v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@5edcf5org.highwire.dtl.DTLVardef@1fc6345org.highwire.dtl.DTLVardef@d9783eorg.highwire.dtl.DTLVardef@1654886_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The penetrance of age-related monogenic disease depends on ascertainment context
Uyenlinh L. Mirshahi, Kevin Colclough, … Kashyap Amratlal Patel·The American Journal of Human GeneticsPeer-reviewed·Oct 17, 2022
- Common Genetic Variants Modify Disease Risk and Clinical Presentation in Monogenic Diabetes
Jacques Murray Leech, Robin N. Beaumont, … Kashyap Amratlal Patel·Nature MetabolismPeer-reviewed·Sep 9, 2025
- Polygenic Background Contributes to GCK-MODY Clinical Presentation and Glycaemic Variability
Jacques Murray Leech, Ankit M Arni, … Kashyap Amratlal Patel·DiabetologiaPeer-reviewed·Mar 18, 2026
- Heterozygous RFX6 protein truncating variants cause Maturity-Onset Diabetes of the Young (MODY) with reduced penetrance
Kashyap Amratlal Patel, Jarno L. T. Kettunen, … Michael N. Weedon·Nature CommunicationsPeer-reviewed·Oct 6, 2017
- Multi-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries.
Alicia Huerta‐Chagoya, Joohyun Kim, … Xiuqing Guo·The Lancet Diabetes & EndocrinologyPeer-reviewed·Apr 27, 2026
- NEUROD1 and PDX1 are low penetrance causes of MODY while rare variants in APPL1 and WFS1 are not associated with MODY
Aparajita Sriram, Matthew Neil Wakeling, … Kashyap Amratlal Patel·medRxiv·May 7, 2025